Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016

Non-DEHP and Phthalate-Free Tubing Now Available for Routine Laboratory Applications

By BiotechDaily International staff writers
Posted on 27 Aug 2013
Print article
A major European manufacturer of high-performance flexible tubing and other plastic laboratory products has introduced a bio-based, phthalate-free product for use in routine laboratory applications.

Saint-Gobain Performance Plastics (Paris, France) the manufacturer of Tygon high-performance flexible tubing, has recently introduced a bio-based, phthalate-free product. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon formulations.

The next-generation DEHP- and phthalate-free Tygon S3 tubing is made with a bio-based plasticizer and the product’s new sustainable formulations are biodegradable and deliver superior pump life. For example, Tygon S3 E-3603 non-DEHP tubing was specially formulated for resistance to flex-fatigue and abrasion. In many peristaltic pump applications, it outlasts the original R-3603 by a factor of three to one. As tubing for an instrumentation connection, vent, drain and other general laboratory applications, Tygon S3 E-3603 Tubing offers superior life, which minimizes the labor and expense of replacement.

New Tygon S3 formulations include Tygon S3 E-3603 General Laboratory Tubing and Tygon S3 E-LFL Long Flexible Life Tubing. Tygon R-1000 has also been replaced by Tygon E-1000, soft and flexible non-DEHP tubing.

“The change to non-DEHP tubing is integral to the company’s continued efforts toward safety, compliance, and sustainability,” said Katia May, laboratory market manager for Saint-Gobain Performance Plastics. “Saint-Gobain is the first manufacturer to remove DEHP and phthalates from tubing products for laboratory applications and beyond. We are committed to providing superior, smart, safe, and sustainable flexible tubing with unsurpassed performance.”

Related Links:


Print article


Drug Discovery

view channel
Image: Positive alpha-synuclein staining of a Lewy body from a patient with Parkinson\'s disease (Photo courtesy of Wikimedia Commons).

Bifunctional Dimer Drugs Prove Effective in Parkinson's Disease Yeast Model

A team of Canadian neurodegenerative disease researchers used a yeast model system to identify novel drug compounds that were able to block the misfolding of alpha- synuclein (AS) protein, which characterizes... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more


view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.